# Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release Tablet

> **NCT01677260** · NA · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 38 (actual)

## Conditions studied

- Metformin XR BE Study in Healthy Volunteers With Single and Multiple Dose

## Interventions

- **DRUG:** 500 mg metformin hydrochloride extended release caplet (test drug)
- **DRUG:** 500 mg metformin hydrochloride prolonged release tablet (reference drug)

## Key facts

- **NCT ID:** NCT01677260
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2009-12
- **Final completion:** 2010-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2012-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677260, "Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release Tablet". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01677260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*